We were located in Hall 11 on Stand A60 with our show partners SFD in the enormous Dusseldorf Messe. The stand itself was a thing of beauty as it provided every sensory experience possible as you walked on the stand. Each entrance contained interactive projected screens with a scented aroma being released periodically from each side of the walkways so the show goers felt at ease as they walked onto the stand.
Each attendee was greeted as they entered the show stand and then left to their own devise to take in all of the new mannequin designs, free drinks and of course our virtual reality.
We chose to release our Virtual Reality software on the first day of Euroshop. From feedback it was apparent it had a huge effect on the show goer’s perspective on the future of retail design. Our software addresses a lot of issues in multiple retail design areas. For example, global brands were attending the show in the hope that they would find a new piece of tech to improve their design process for store layouts, We are just that. They expressed their frustrations about the time and money they were wasting on mock stores and the ambiguity currently in place that makes it difficult for their team to reach sign off for their store roll outs. The value of our software is that it has been developed by the people who have experienced these frustrations and have managed to eliminate them through an immersive and fully interactive VR software.
We showcased different scenes for different areas in the retail industry such as store layouts, mannequin design & visual merchandising. Our software takes what people see in 2D everyday and brings it to life through VR. It was great to hear from global brands that they see our software as a cutting edge solution to their problems.
As for the rest of the show, it was exciting to see that there are so many cool developments going on in the retail industry. Here are some of the highlights we managed to capture:
A final congratulations to SFD who managed to be in the top 10 stands out of 2000+ exhibitors.